The Cell Biology of LRRK2 in Parkinson's Disease.

Mol Cell Biol

Department of Pathology, University of California, San Diego, San Diego, California, USA

Published: April 2021

Point mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease (PD) and are implicated in a significant proportion of apparently sporadic PD cases. Clinically, LRRK2-driven PD is indistinguishable from sporadic PD, making it an attractive genetic model for the much more common sporadic PD. In this review, we highlight recent advances in understanding LRRK2's subcellular functions using LRRK2-driven PD models, while also considering some of the limitations of these model systems. Recent developments of particular importance include new evidence of key LRRK2 functions in the endolysosomal system and LRRK2's regulation of and by Rab GTPases. Additionally, LRRK2's interaction with the cytoskeleton allowed elucidation of the LRRK2 structure and appears relevant to LRRK2 protein degradation and LRRK2 inhibitor therapies. We further discuss how LRRK2's interactions with other PD-driving genes, such as the , , and genes, may highlight cellular pathways more broadly disrupted in PD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088268PMC
http://dx.doi.org/10.1128/MCB.00660-20DOI Listing

Publication Analysis

Top Keywords

parkinson's disease
8
lrrk2
6
cell biology
4
biology lrrk2
4
lrrk2 parkinson's
4
disease point
4
point mutations
4
mutations leucine-rich
4
leucine-rich repeat
4
repeat kinase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!